Quantcast
Last updated on June 19, 2013 at 21:21 EDT

Latest Organ transplant Stories

2013-04-22 12:30:30

OTTAWA, April 22, 2013 /CNW/ - Today in Ottawa, Hélène Campbell announced the Give2Live Campaign, a social media effort that uses crowdfunding to support the needs of those waiting for transplants throughout Canada. "Many patients waiting for an organ transplant at Toronto General Hospital and other transplant centres are required to live within two hours of the hospital," said Ms. Campbell.  "More often than not, this means uprooting from their home and finding new housing...

2013-02-05 16:23:28

LEE'S SUMMIT, Mo., Feb. 5, 2013 /PRNewswire/ -- Viracor-IBT Laboratories, Inc. announced today that it has signed a definitive agreement to purchase the assets of Cylex(TM), Inc., a global life sciences company focused on the development, manufacturing and commercialization of in vitro diagnostic products intended to illuminate immunity in the area of transplant medicine. This includes the acquisition of Cylex's core product, ImmuKnow®, a noninvasive biomarker of immune function...

2012-11-26 04:22:21

BLUE BELL, Pa., Nov. 26, 2012 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that testing of multiple synthetic vaccine constructs for cytomegalovirus (CMV) induced robust T cells in mice, demonstrating the potential for a SynCon® DNA vaccine to treat this virus that causes infant death and congenital abnormalities, is associated with cerebral palsy and brain tumors, and is the most common viral infection in organ transplant recipients. CMV...

2012-08-15 02:26:25

TUCSON, Ariz., Aug. 15, 2012 /PRNewswire/ -- SynCardia Systems, Inc. (www.syncardia.com), manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that Evangelischen und Johanniter Klinikum Niederrhein (EJK Duisburg) in Germany has become one of the most active SynCardia Certified Centers in Europe. (Photo: http://photos.prnewswire.com/prnh/20120815/LA57714) "End-stage biventricular heart failure is a lethal...

2012-08-09 02:28:47

TUCSON, Ariz., Aug. 9, 2012 /PRNewswire/ -- SynCardia Systems, Inc. (www.syncardia.com), manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart, announced today record-setting revenue for the quarter ended June 30, 2012, marking the company's best quarter to date and its fifth consecutive profitable quarter. (Photo: http://photos.prnewswire.com/prnh/20120809/LA54747) "Although many companies in the mechanical circulatory support space...

2012-08-08 11:36:37

Respecting a veto is 'unethical, unprofessional, and against the spirit of the law' says ethicist It has recently been suggested that patients should be kept alive using elective ventilation to facilitate the harvesting of organs for donation. But David Shaw, Honorary Lecturer at the University of Aberdeen believes there is a much simpler way to increase the number of donated organs – by ensuring that doctors respect the wishes of the deceased and over-rule any veto. Veto by the...

2012-08-07 10:26:28

SAN ANTONIO, Aug. 7, 2012 /PRNewswire-USNewswire/ -- For kidney failure patients with living donors who are not a match, kidney paired donation offers an alternative with outstanding results, concludes a study published in this month's edition of the American Journal of Transplantation. Doctors at Methodist Specialty and Transplant Hospital published the article, "Single-Center Kidney Paired Donation: The Methodist San Antonio Experience," based on the results of a three-year study on...

2012-08-07 10:26:00

NEW YORK, Aug. 7, 2012 /PRNewswire/ -- Islet Sciences, Inc., (OTCBB: ISLT) a biotechnology company engaged in the research, development and commercialization of patented technologies in the field of transplantation therapy for patients with diabetes, today announced that it has signed a strategic alliance with Spring Point Project. Spring Point Project's team has unique experience under the current Good Manufacturing Practices (cGMP) required by U.S. Food and Drug Administration...

2012-08-06 02:25:38

BERLIN, August 6, 2012 /PRNewswire/ -- - Cross reference: Picture is available at epa european pressphoto agency (http://www.epa.eu) and http://www.presseportal.de/pm/63857 - For the first time in the history of Japan it was possible for doctors at the University of Tokyo, on August 2, 2012, to save a small child who was seriously suffering from a severe heart condition, aided by a Berlin Heart EXCOR(R) ventricular assist device. From a medical point of view the...

2012-07-28 23:02:37

Hair transplant will be broadcast live on TheBaldTruth.com on July 30, 2012 at 11:00 a.m. PST. Walnut Creek, CA (PRWEB) July 27, 2012 Bay Area hair restoration surgeon, Sara Wasserbauer, M.D., will perform a pro bono hair transplant on a young man who battled a brain tumor eight years ago. The surgery will be broadcast live on TheBaldTruth.com on July 30, 2012 at 11:00 a.m. PST. Carlos Cabrera was just 18 years old when he was diagnosed with a rare brain tumor called ganlioglioma. He...


Latest Organ transplant Reference Libraries

0_886104d1c1c698f3a531e056704457d5
2010-10-14 16:46:25

The artificial heart, a mechanical heart replacement, is typically used in order to bridge the time to heart transplant or to replace the heart in case a transplant is impossible. Often ventricular assist devices are confused with mechanical hearts because the assist the heart through pumps. They are also different from a cardiopulmonary bypass machine which is an external device used to provide the function of the heart and lungs. CPBs are usually only used for a few hours at a time,...

More Articles (1 articles) »